glp 1 agonist dementia GLP-1 Medications Associated with Reduced Likelihood of Compared to Other Diabetic Meds Comparative dementia risk with GLP1

Despite the side effects and murky insurance coverage, GLP-1s are becoming more common weight loss interventions

At the 3.0 mg daily dose, liraglutide produced average weight losses on the order of ~8% in pivotal trials (SCALE program), with additional benefits in glycemic measures and cardiometabolic risk markers

doi: 10.1152/PHYSREV.00034.2006 8 RajagopalDAl RashidSPrasadMFareedM

JM was encouraged to call the clinic with any questions or concerns

Food & Drug Administration, Current and Resolved Drug Shortages and Discontinuations Reported to FDA (2025)

In a study, scientists investigated the role of GLP- 1 and GIP on central cells in regulating body weight homeostasis [79]